These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 23055354)
1. [Symptom-oriented follow-up of early breast cancer compared to intensive surveillance. Results of a prospective multicentre study: update and 10-year overall survival]. Bornhak S; Heidemann E; Meisner C; Herschlein HJ; Simon W; Merkle E; Schmidt B; Metzger H; Rössle S; Brinkmann F Dtsch Med Wochenschr; 2012 Oct; 137(42):2142-8. PubMed ID: 23055354 [TBL] [Abstract][Full Text] [Related]
2. Symptom-oriented follow-up of early breast cancer is not inferior to conventional control. Results of a prospective multicentre study. Bornhak S; Heidemann E; Herschlein HJ; Simon W; Merkle E; Widmaier G; Ernst R; Greulich M; Bittner R; Kieninger G; Merkle P; Strosche H; Karg C; Wellhaeusser U; Aulitzky W; Schmidt B; Metzger H; Hahn M; Stauch A; Meisner C; Selbmann HK; Regelmann C; Brinkmann F Onkologie; 2007 Sep; 30(8-9):443-9. PubMed ID: 17848816 [TBL] [Abstract][Full Text] [Related]
3. Early-stage young breast cancer patients: impact of local treatment on survival. Bantema-Joppe EJ; de Munck L; Visser O; Willemse PH; Langendijk JA; Siesling S; Maduro JH Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e553-9. PubMed ID: 21601378 [TBL] [Abstract][Full Text] [Related]
4. Aspects of survival from colorectal cancer in Denmark. Iversen LH Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726 [TBL] [Abstract][Full Text] [Related]
5. Impact of screening and risk factors for local recurrence and survival after conservative surgery and radiotherapy for early breast cancer: results from a large series with long-term follow-up. Kunkler IH; Kerr GR; Thomas JS; Jack WJ; Bartlett JM; Pedersen HC; Cameron DA; Dixon JM; Chetty U; Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):829-38. PubMed ID: 22197227 [TBL] [Abstract][Full Text] [Related]
6. Follow-up after treatment for breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. CMAJ; 1998 Feb; 158 Suppl 3():S65-70. PubMed ID: 9484280 [TBL] [Abstract][Full Text] [Related]
7. Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark. Christiansen P; Bjerre K; Ejlertsen B; Jensen MB; Rasmussen BB; Lænkholm AV; Kroman N; Ewertz M; Offersen B; Toftdahl DB; Møller S; Mouridsen HT; J Natl Cancer Inst; 2011 Sep; 103(18):1363-72. PubMed ID: 21881042 [TBL] [Abstract][Full Text] [Related]
8. Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials. Fisher B; Jeong JH; Anderson S; Wolmark N J Natl Cancer Inst; 2004 Dec; 96(24):1823-31. PubMed ID: 15601638 [TBL] [Abstract][Full Text] [Related]
9. Can locoregional treatment of the primary tumor improve outcomes for women with stage IV breast cancer at diagnosis? Nguyen DH; Truong PT; Alexander C; Walter CV; Hayashi E; Christie J; Lesperance M Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):39-45. PubMed ID: 22330986 [TBL] [Abstract][Full Text] [Related]
10. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients]. Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207 [TBL] [Abstract][Full Text] [Related]
11. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer. Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137 [TBL] [Abstract][Full Text] [Related]
12. "Axillary recurrences after sentinel lymph node biopsy: a multicentre analysis and follow-up of sentinel lymph node negative breast cancer patients". van Wely BJ; van den Wildenberg FJ; Gobardhan P; van Dalen T; Borel Rinkes IH; Theunissen EB; Wijsman JH; Ernst M; van der Pol CC; Madsen EV; Vles WJ; Wauters CA; de Wilt JH; Strobbe LJ Eur J Surg Oncol; 2012 Oct; 38(10):925-31. PubMed ID: 22633152 [TBL] [Abstract][Full Text] [Related]
13. Is conservative surgery a good option for patients with "triple negative" breast cancer? Martinez-Ramos D; Escrig-Sos J; Torrella-Ramos A; Alcalde-Sanchez M; Salvador-Sanchis JL Breast; 2012 Jun; 21(3):401-5. PubMed ID: 22579462 [TBL] [Abstract][Full Text] [Related]
14. Disease-specific survival in patient-detected breast cancer. Kaplan HG; Malmgren JA Clin Breast Cancer; 2006 Jun; 7(2):133-40. PubMed ID: 16800972 [TBL] [Abstract][Full Text] [Related]
15. Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma. Grann VR; Troxel AB; Zojwalla NJ; Jacobson JS; Hershman D; Neugut AI Cancer; 2005 Jun; 103(11):2241-51. PubMed ID: 15844176 [TBL] [Abstract][Full Text] [Related]
16. Reproductive history and mortality after breast cancer diagnosis. Whiteman MK; Hillis SD; Curtis KM; McDonald JA; Wingo PA; Marchbanks PA Obstet Gynecol; 2004 Jul; 104(1):146-54. PubMed ID: 15229014 [TBL] [Abstract][Full Text] [Related]
17. Treatment of early breast cancer, a long-term follow-up study: the GOCS experience. Iturbe J; Zwenger A; Leone JP; Verdera PP; Vallejo C; Romero A; Perez J; Machiavelli M; Leone B Breast J; 2011; 17(6):630-7. PubMed ID: 22050282 [TBL] [Abstract][Full Text] [Related]
18. Does local recurrence affect the rate of distant metastases and survival in patients with early-stage breast carcinoma treated with breast-conserving therapy? Vicini FA; Kestin L; Huang R; Martinez A Cancer; 2003 Feb; 97(4):910-9. PubMed ID: 12569590 [TBL] [Abstract][Full Text] [Related]